MedTech Venture Partners is a venture capital firm based in Menlo Park, California, focused on seed and early-stage medical device companies developing novel therapeutic and diagnostic technologies. The firm's team brings extensive operational experience in medical device development, launch, and scaling.
80% of their portfolio is in Healthcare. Their most common stage is series-c (40% of deals). Average disclosed round size is $60.5M (across 4 rounds with reported amounts).
Portfolio
3
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 GT Medical Technologies | Series D | $37M | Jan 2025 |
| GT Medical Technologies | Series C | $45M | Mar 2023 |
 Reyedar | Seed | — | Jan 2023 |
| PPQ Bypass | Series C | $60M | Jan 2019 |
| GT Medical Technologies | Series E | $100M | — |
Top Co-Investors
Gilde Healthcare3 shared
Evidity Health Capital2 shared
VMG Partners1 shared
Nexus Venture Partners1 shared
Lightspeed Venture Partners1 shared
Bluestone Equity Partners1 shared
Cottonwood Technology Fund1 shared
Uneti Ventures1 shared
Accelmed Partners1 shared
Viking Global Investors1 shared
Seroba Life Sciences1 shared
Deerfield1 shared
Last updated: 14 September 2026